fda update tirzepatide Prescriber Insights: Navigating Updates on Semaglutide & for Clinicians FDA approval for Zepbound (tirzepatide)

Clinical trials for the branded medication showed significant weight loss, and many patients using the compounded version report comparable results

Rather, understanding your genetic profile may support a more personalized conversation with your provider about whether GLP-1 therapy aligns with your metabolic pattern and whether compounded options should be considered alongside Medicaid coverage pathways

Some people on Ozempic already deal with sleep changes or low energy

Hangry in the field: An experience sampling study on the impact of hunger on anger, irritability, and affect

230 In high-fat diet-induced MASLD models, naringin improves liver function, reflected by decreased serum ALT and AST levels